BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7944295)

  • 1. Trinucleotide repeat length and rate of progression of Huntington's disease.
    Illarioshkin SN; Igarashi S; Onodera O; Markova ED; Nikolskaya NN; Tanaka H; Chabrashwili TZ; Insarova NG; Endo K; Ivanova-Smolenskaya IA
    Ann Neurol; 1994 Oct; 36(4):630-5. PubMed ID: 7944295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
    Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
    Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trinucleotide repeat length instability and age of onset in Huntington's disease.
    Duyao M; Ambrose C; Myers R; Novelletto A; Persichetti F; Frontali M; Folstein S; Ross C; Franz M; Abbott M
    Nat Genet; 1993 Aug; 4(4):387-92. PubMed ID: 8401587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
    Kremer B; Goldberg P; Andrew SE; Theilmann J; Telenius H; Zeisler J; Squitieri F; Lin B; Bassett A; Almqvist E
    N Engl J Med; 1994 May; 330(20):1401-6. PubMed ID: 8159192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.
    Warner JP; Barron LH; Brock DJ
    Mol Cell Probes; 1993 Jun; 7(3):235-9. PubMed ID: 8366869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
    Snell RG; MacMillan JC; Cheadle JP; Fenton I; Lazarou LP; Davies P; MacDonald ME; Gusella JF; Harper PS; Shaw DJ
    Nat Genet; 1993 Aug; 4(4):393-7. PubMed ID: 8401588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAG mutation effect on rate of progression in Huntington's disease.
    Squitieri F; Cannella M; Simonelli M
    Neurol Sci; 2002 Sep; 23 Suppl 2():S107-8. PubMed ID: 12548366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease: diagnosis by amplification of the CAG repeat.
    Upton JD; Avery S; Parkin P; George PM
    N Z Med J; 1995 Mar; 108(995):78-80. PubMed ID: 7891947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of CAG repeat length with clinical progression in Huntington disease.
    Rosenblatt A; Liang KY; Zhou H; Abbott MH; Gourley LM; Margolis RL; Brandt J; Ross CA
    Neurology; 2006 Apr; 66(7):1016-20. PubMed ID: 16606912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAG repeat number governs the development rate of pathology in Huntington's disease.
    Penney JB; Vonsattel JP; MacDonald ME; Gusella JF; Myers RH
    Ann Neurol; 1997 May; 41(5):689-92. PubMed ID: 9153534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
    Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
    Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
    Vassos E; Panas M; Kladi A; Vassilopoulos D
    J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].
    Benítez J; Fernández E; García Ruiz P; Robledo M; Ayuso C; García Yébenes J
    Rev Clin Esp; 1994 Aug; 194(8):591-3. PubMed ID: 7938836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of the CAG triplet repeats region in the Huntington disease gene (IT15) in several mammalian species.
    Pêcheux C; Gall AL; Kaplan JC; Dodé C
    Ann Genet; 1996; 39(2):81-6. PubMed ID: 8766138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
    Spiegel R
    Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the Huntington's disease gene in New Zealand.
    Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
    N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Huntington chorea: (CAG)n repeats on gene IT 15 in Austria].
    Meszaros K; Willinger U; Heiden AM; Fuchs K; Baumhackl U; Brücke T; Feucht M; Fathi N; Lenzinger E; Miller E
    Wien Klin Wochenschr; 1994; 106(21):671-2. PubMed ID: 7810152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal gene product identified in Huntington's disease lymphocytes and brain.
    Ide K; Nukina N; Masuda N; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 1995 Apr; 209(3):1119-25. PubMed ID: 7733967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.